The invention relates to an in vitro assay for pancreatic ductal adenocarcinoma, preferably an immunoassay, wherein the assay is based on the determination of anti-ezrin auto-antibodies in a biological sample from a subject suspected of being affected by pancreatic ductal adenocarcinoma or from a subject whose predisposition to pancreatic ductal adenocarcinoma one desires to determine.

A method and a kit for the in vitro diagnosis of pancreatic ductal adenocarcinoma or for determining the predisposition to pancreatic ductal adenocarcinoma

NOVELLI, Francesco;CAPELLO, Michela;CAPPELLO, Paola
2012

Abstract

The invention relates to an in vitro assay for pancreatic ductal adenocarcinoma, preferably an immunoassay, wherein the assay is based on the determination of anti-ezrin auto-antibodies in a biological sample from a subject suspected of being affected by pancreatic ductal adenocarcinoma or from a subject whose predisposition to pancreatic ductal adenocarcinoma one desires to determine.
WO2013186748 A1
NatiMab Therapeutics srl
F. Novelli; M. Capello; P. Cappello
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/158436
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact